Canagliflozin Dimer Impurity
 
		Product Description
CAT No.
				
									ALN-C010024								
				CAS No.
				
									NA								
				Mol. F.
				
									C48H50F2O11S2								
				Mol. Wt.
				
									905								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (3S,4R,5R)-1-(2-Fluoro-5-(5-(2-methyl-5-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)benzyl)thiophen-2-yl)phenyl)-1-(3-((5-(4-fluorophenyl)thiophen-2yl)methyl)-4-methylphenyl)hexan-1,2,3,4,5,6-hexaol								
				
									Smiles : OC(C1=CC=C(C)C(CC2=CC=C(C3=CC=C(F)C=C3)S2)=C1)(C4=CC(C5=CC=C(CC6=CC([C@H]7[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O7)=CC=C6C)S5)=CC=C4F)C(O)[C@@H](O)[C@H](O)[C@H](O)CO								
				
									Inchi : InChI=1S/C9H5NO2/c10-4-6-2-1-3-7-8(6)5-12-9(7)11/h1-3H,5H2								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Development and validation of HPLC method for determination of trace level potential genotoxic hydroperoxide impurity in canagliflozin
									By Gosar, Amit; Shaikh, Tabrez; Botkondle, Suresh; Mahadik, Neelam; Tole, RahulnFrom International Journal of Pharma Research and Health Sciences (2019), 7(5), 3068-3071								
				Bioanalytical method development and validation of canagliflozin in human plasma by liquid chromatography-tandem mass spectrometry
									By Deepan, T.; Rao, M. V. Basaveswara; Dhanaraju, M. D. – From Asian Journal of Pharmaceutical and Clinical Research (2019), 12(8), 46-51								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            